Flexible barrier films containing cyclic olefins

US10335308B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10335308-B2
Application numberUS-201214367275-A
CountryUS
Kind codeB2
Filing dateDec 13, 2012
Priority dateDec 22, 2011
Publication dateJul 2, 2019
Grant dateJul 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various polymeric barrier compositions are described which when formed into films, are useful in reducing transmission of odors. The films can be incorporated into a wide range of products such as multilayer barrier films used in medical applications and particularly in ostomy appliances. In certain versions, the films include blends of amorphous cyclic olefin copolymers and semi-crystalline cyclic olefin copolymers.

First claim

Opening claim text (preview).

What is claimed is: 1. A multilayer barrier film comprising: at least one layer including a blend of cyclic olefin copolymers (COC), wherein the blend includes a semi-crystalline COC and a norbornene COC, wherein a total norbornene concentration of the norbornene COC in the at least one layer is from about 12% to about 60% by mole based upon the total moles of COCs in the layer; and a secondary barrier layer including ethylene vinyl alcohol (EVOH); wherein the semi-crystalline cyclic olefin copolymer has a glass transition temperature of from about −20° C. to about 20° C. 2. The multilayer barrier film of claim 1 , wherein the total norbornene concentration of the norbornene COC in the at least one layer is from about 15% to about 55% based upon the total moles of COCs in the layer. 3. The multilayer barrier film of claim 1 , wherein the at least one layer includes (i) a first layer including a semi-crystalline cyclic olefin copolymer (COC), and (ii) a second layer including a semi-crystalline cyclic olefin copolymer. 4. The multilayer barrier film of claim 3 , wherein the semi-crystalline cyclic olefin copolymer in the first layer is the same as the semi-crystalline cyclic olefin copolymer in the second layer. 5. The multilayer barrier film of claim 1 , wherein the ethylene vinyl alcohol has an ethylene content of from about 25% to about 50% by mole. 6. The multilayer barrier film of claim 5 , wherein the ethylene vinyl alcohol has an ethylene content of from about 32% to about 48% by mole. 7. The multilayer barrier film of claim 6 , wherein the ethylene vinyl alcohol has an ethylene content of from about 34% to about 48% by mole. 8. The multilayer barrier film of claim 1 , wherein the at least one layer including the semi-crystalline cyclic olefin copolymer also includes at least one amorphous cyclic olefin copolymer. 9. A multilayer barrier film comprising: at least one layer including a blend of cyclic olefin copolymers (COC), wherein the blend inclues a semi-crystalline COC and a norbornene COC, wherein a total norbornene concentration of the norbornene COC in the at least one layer is from about 12% to about 60% by mole based upon the total moles of COCs in the layer; and a secondary barrier layer including ethylene vinyl alcohol (EVOH); and at least one flexible support layer including one or more polymers selected from the group consisting of styrenic elastomers, polyolefins, and polyolefin elastomers and combinations thereof; wherein the one or more polymers has a density of from about 0.75 to about 1.10 g/cm 3 . 10. The multilayer barrier film of claim 9 , wherein the one or more polymers has a density of from about 0.85 to about 1.01 g/cm 3 . 11. The multilayer barrier film of claim 10 , wherein the density is from about 0.860 to about 0.95 g/cm 3 . 12. The multilayer barrier film of claim 9 , wherein the one or more polymers has a melt flow index of from about 0.1 to about 1,000 g/10 min. 13. The multilayer barrier film of claim 12 , wherein the one or more polymers has a melt flow index from about 0.5 to about 100 g/10 min. 14. The multilayer barrier film of claim 1 , further comprising: an inner antimicrobial layer including at least one antimicrobial agent. 15. An article comprising the multilayer barrier film of claim 1 . 16. The article of claim 15 , wherein the article is an ostomy pouch. 17. A multilayer barrier film comprising: at least one layer including semi-crystalline cyclic olefin copolymer (COC) having a melting temperature (Tm) of from about 70° C. to about 120° C., a glass transition temperature (Tg) of from about −20° C. to about 20° C. and a norbornene COC, wherein a norbornene content of the norbornene COC in the at least one layer is from about 12% to about 60% by mole based upon the total moles of COCs in the layer. 18. The multilayer barrier film of claim 17 , wherein the at least one layer includes (i) a first layer including a semi-crystalline cyclic olefin copolymer (COC), and (ii) a second layer including a semi-crystalline cyclic olefin copolymer. 19. The multilayer barrier film of claim 18 , wherein the semi-crystalline cyclic olefin copolymer in the first layer is the same as the semi-crystalline cyclic olefin copolymer in the second layer. 20. The multilayer barrier film of claim 17 , further comprising: a secondary barrier layer including ethylene vinyl alcohol (EVOH). 21. The multilayer barrier film of claim 17 , wherein the ethylene vinyl alcohol has an ethylene content of from about 25% to about 50% by mole. 22. The multilayer barrier film of claim 17 , wherein the ethylene vinyl alcohol has an ethylene content of from about 32% to about 48% by mole. 23. The multilayer barrier film of claim 17 , wherein the ethylene vinyl alcohol has an ethylene content of from about 34% to about 48% by mole. 24. The multilayer barrier film of claim 17 , wherein the at least one layer including the semi-crystalline cyclic olefin copolymer also includes at least one amorphous cyclic olefin copolymer. 25. The multilayer barrier film of claim 17 , further comprising: at least one flexible support layer including one or more polymers selected from the group consisting of styrenic elastomers, polyolefins, and polyolefin elastomers and combinations thereof. 26. The multilayer barrier film of claim 25 , wherein the one or more polymers has a density of from about 0.75 to about 1.10 g/cm 3 . 27. The multilayer barrier film of claim 26 , wherein the one or more polymers has a density of from about 0.85 to about 1.01 g/cm 3 . 28. The multilayer barrier film of claim 27 , wherein the density is from about 0.860 to about 0.95 g/cm 3 . 29. The multilayer barrier film of claim 25 , wherein the one or more polymers has a melt flow index of from about 0.1 to about 1,000 g/10 min. 30. The multilayer barrier film of claim 29 , wherein the one or more polymers has a melt flow index of from about 0.5 to about 100 g/10 min. 31. The multilayer barrier film of claim 17 , further comprising an inner antimicrobial layer including at least one antimicrobial agent. 32. An article comprising the multilayer barrier film of claim 17 . 33. The article of claim 32 , wherein the article is an ostomy pouch. 34. A method for reducing transmission of odorous species, the method comprising: providing at least one layer including a blend of cyclic olefin copolymers (COC), wherein the blend includes a semi-crystalline COC and a norbornene COC, wherein a total norbornene concentration of the norbornene COC in the at least one layer is from about 12% to about 60% by mole based upon the total moles of COCs in the layer; forming a barrier film including the at least one layer including a blend of cyclic olefin copolymers (COC); and positioning the barrier film between a source of odorous species and a user; wherein the semi-crystalline cyclic olefin copolymer has a glass transition temperature of from about −20° C. to about 20° C. 35. The method of claim 34 , wherein the total norbornene concentration in the layer is from about 15% to about 55% by mole. 36. The method of claim 34 , wherein the odorous species is selected from the group consisting of skatole and hydrogen sulfide.

Assignees

Inventors

Classifications

  • Bags · CPC title

  • Physical, chemical or physicochemical properties · CPC title

  • Polymer of monoethylenically unsaturated hydrocarbon · CPC title

  • All polymers belonging to those covered by groups B32B27/32 and B32B27/30 · CPC title

  • comprising polycycloolefins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10335308B2 cover?
Various polymeric barrier compositions are described which when formed into films, are useful in reducing transmission of odors. The films can be incorporated into a wide range of products such as multilayer barrier films used in medical applications and particularly in ostomy appliances. In certain versions, the films include blends of amorphous cyclic olefin copolymers and semi-crystalline cy…
Who is the assignee on this patent?
Avery Dennison Corp
What technology area does this patent fall under?
Primary CPC classification A61F5/441. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).